5 Patents
- US126166852026Concomitant Administration of Glucocorticoid Receptor Modulator Relacorilant and CYP2C9 Substrates
Corcept Therapeutics Incorporated
0 cites - US125890942026Concomitant Administration of Glucocorticoid Receptor Modulator Relacorilant and Paclitaxel, a Dual Substrate of CYP2C8 and CYP3A4
Corcept Therapeutics Incorporated
0 cites - US124404872025Method of Normalizing the Neutrophil to Lymphocyte Ratio in Cancer Patients with a Selective Glucocorticoid Receptor Antagonist
Corcept Therapeutics Incorporated
0 cites - US124338822025Treatments for Amyotrophic Lateral Sclerosis Using Dazucorilant
Corcept Therapeutics Incorporated
0 cites - US119446172024Concomitant Administration of Glucocorticoid Receptor Modulator Relacorilant and Paclitaxel, a Dual Substrate of CYP2C8 and CYP3A4
Corcept Therapeutics Incorporated
0 cites